Fig. 3From: Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective studyROC curves for discriminating patients with TRG3 and those with non-TRG3 according to values of the SII (A) and PNI (B)Back to article page